Change of Director's Interest Notice SW
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.s
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given
to ASX become ASX’s property and made be made public.
Introduced 30/09/2001
Name of entity:
Emerald Clinics Limited
ABN:
625 085 734
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director:
Stewart Washer
Date of last notice:
11/03/2020
Part 1 - Change of director’s relevant interests in securities
Note: In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. In the case of a
company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest
Direct and Indirect
Nature of indirect interest (including
registered holder)
Dr Stewart James Washer & Dr Patrizia Derna
Washer <The Washer Family Superannuation
Fund>
(Dr Washer is a trustee and beneficiary of the
Note: Provide details of the circumstances giving rise to
the relevant interest.
superannuation fund)
Dr Stewart James Washer & Dr Patrizia Derna
Washer <The Washer Family Trust>
(Dr Washer is a trustee and beneficiary of the Trust)
Mal Washer Nominees Pty Ltd <Mal Washer
Family A/C>
(Dr Washer is a trustee and beneficiary of the trust)
Date of change
16/03/2020
No. of securities held prior to change
Dr Stewart James Washer & Dr Patrizia Derna
Washer <The Washer Family Superannuation
Fund>
(Dr Washer is a trustee and beneficiary of the
superannuation fund)Dr Stewart James Washer &
Dr Patrizia Derna Washer <The Washer Family
Trust>
450,499 Ordinary Shares ( -100 shares correction)
Mal Washer Nominees Pty Ltd <Mal Washer
Family A/C>
19,600,000 Ordinary Shares
28,400,000 Ordinary Shares
1,500,000 Unlisted Options
exercisable at $0.45 expiring 13 June 2023
(Dr Washer is a trustee and beneficiary of the Trust)
(Dr Washer is a trustee and beneficiary of the trust)
+ See chapter 19 for defined terms
Appendix 3Y pg. 1
Appendix 3Y
Change of Director’s Interest Notice
Class changed
Ordinary Shares
Number acquired
100,000
Number disposed
-
Value/Consideration
$6,110.00
Note: If consideration is non-cash, provide details and
estimated valuation
No. of securities held after change
Dr Stewart James Washer & Dr Patrizia Derna
Washer <The Washer Family Superannuation
Fund>
(Dr Washer is a trustee and beneficiary of the
550,499 Ordinary Shares ( -100 shares correction)
Dr Stewart James Washer & Dr Patrizia Derna
Washer <The Washer Family Trust>
28,400,000 Ordinary Shares
1,500,000 Unlisted Options
Mal Washer Nominees Pty Ltd <Mal Washer
Family A/C>
19,600,000 Ordinary Shares
Nature of change
On market purchases
superannuation fund)
(Dr Washer is a trustee and beneficiary of the Trust)
(Dr Washer is a trustee and beneficiary of the trust)
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment
plan, participation in buy-back
exercisable at $0.45 expiring 13 June 2023
Part 2 - Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder (if issued securities)
N/A
Date of change
N/A
No. and class of securities to which interest related prior
to change
N/A
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Interest after changes
N/A
Note: Details are only required for a contract in relation to which the
interest has changed
Note: if consideration is non-cash, provide details and an estimated
valuation
+ See chapter 19 for defined terms
Appendix 3Y pg. 2
Appendix 3Y
Change of Director’s Interest Notice
Part 3 – Closed Period
Were the interests in the securities or contracts
detailed above traded during a +closed period
where prior written clearance was required?
No
If so, was prior written clearance provided to
allow the trade to proceed during this period?
N/A
If prior written clearance was provided, on
what date was this provided?
N/A
+ See chapter 19 for defined terms
Appendix 3Y pg. 3
Share your feedback
Discover